Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001403916-10-000003
Filing Date
2010-09-10
Accepted
2010-09-10 15:35:31
Documents
1
Effectiveness Date
2010-09-10
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10901
  Complete submission text file 0001403916-10-000003.txt   12316
Mailing Address 2425 55TH STREET, SUITE 100 BOULDER CO 80301
Business Address 2425 55TH STREET, SUITE 100 BOULDER CO 80301 (720) 544-6857
OPX Biotechnologies Inc (Filer) CIK: 0001403916 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-147586 | Film No.: 101066517